Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of ...

In this offering, I shall call attention to a remarkable leap of imagination by pediatrician Clemens Freiherr (Baron) von Pirquet. In 1903, based upon purely clinical observations, the 29-year-old ...

Vibrant, traditional, and modern, Russia’s two major cultural centers represent centuries of the country’s rich and turbulent ...

Dr. Chaya Sima Koenigsberg is an assistant professor of Judaic studies at Lander College for Women/The Anna Ruth and Mark Hasten School. In Print Word Prompt – SHEMA – Chaya Sima Koenigsberg ...

In 1190, during the Third Crusade, the Domus Hospitalis Sanctæ Mariæ Teutonicorum Hierosolymitanorum (Order of the Teutonic ...

More than 30 Harvard affiliates delivered a box containing 452 discrimination complaints to Massachusetts Hall at a Monday ...

A Lancaster University student, keen to find out about a special collection held by the University’s Library, got a big ...

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA Ph: +1-203-852-6800, 800-243-6002 ...

SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis ...